Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/29/1998 | CA2287495A1 Materials and methods for treatment of retinal diseases |
10/29/1998 | CA2287344A1 Materials and methods relating to inhibiting the interaction of p53 and mdm2 |
10/29/1998 | CA2287314A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies |
10/29/1998 | CA2287254A1 Mammalian cytokines; related reagents and methods |
10/29/1998 | CA2286933A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins |
10/29/1998 | CA2286865A1 Edg-1-like receptor |
10/29/1998 | CA2286612A1 Treatment for diabetes |
10/29/1998 | CA2286548A1 Fibroblasts with a foreign gene-containing composition for treating wounds |
10/29/1998 | CA2284729A1 Neoglycoproteins |
10/29/1998 | CA2283854A1 Gastrin receptor-avid peptide conjugates |
10/29/1998 | CA2283755A1 Human complement c3-degrading proteinase from streptococcus pneumoniae |
10/29/1998 | CA2259243A1 Method of treating hypertension using a composition containing a dried animal stomach mucosa and endogenous protease-inhibitor peptides |
10/29/1998 | CA2236131A1 Emulsion preconcentrate comprising a cyclosporin propylene carbonate and glycerides |
10/28/1998 | EP0874053A2 3-Dehydroquinate synthase (aroB) |
10/28/1998 | EP0874052A2 Nucleic acid encoding a human protein phosphatase |
10/28/1998 | EP0874051A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines. |
10/28/1998 | EP0874050A2 Integrin ligand ITGL-TSP |
10/28/1998 | EP0874049A1 Nucleic acid sequences of CIITA genes |
10/28/1998 | EP0874048A2 Human hedgehog protein |
10/28/1998 | EP0874047A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor |
10/28/1998 | EP0874046A1 A novel signal transduction factor and a gene encoding the same |
10/28/1998 | EP0874045A1 Novel dnas and process for producing proteins by using the same |
10/28/1998 | EP0873998A2 Receptor protein and its use |
10/28/1998 | EP0873997A1 Teicoplanin derivatives |
10/28/1998 | EP0873996A1 Process of deacylation of teicoplanin and product thereby obtained |
10/28/1998 | EP0873755A1 Prevention and treatment of enterohemorrhagic E. coli infection |
10/28/1998 | EP0873751A2 Pharmaceutical product for application to uterus mucosa |
10/28/1998 | EP0873491A1 Ceramic packing with channels for thermal and catalytic beds |
10/28/1998 | EP0873423A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
10/28/1998 | EP0873417A1 Compositions for the detection of proteases in biological samples and methods of use thereof |
10/28/1998 | EP0873415A1 Fusion protein delivery system and uses thereof |
10/28/1998 | EP0873414A1 Galactopyranosides and their use |
10/28/1998 | EP0873409A1 Equine rhinovirus 1 proteins |
10/28/1998 | EP0873408A1 Calcium binding proteolipid compositions and methods |
10/28/1998 | EP0873407A1 Apo-2 ligand |
10/28/1998 | EP0873406A2 Protein induced by deprenyl |
10/28/1998 | EP0873404A1 Angiotensin converting enzyme inhibitors |
10/28/1998 | EP0873400A1 Delivery of bioactive compounds to an organism |
10/28/1998 | EP0873363A1 Novel high affinity human antibodies to tumor antigens |
10/28/1998 | EP0873360A1 Transforming growth factor alpha hiii |
10/28/1998 | EP0873359A1 Regulator of cell proliferation |
10/28/1998 | EP0873357A2 Antithrombotic agents and methods of use |
10/28/1998 | EP0873356A1 Novel dipeptide amidines as thrombin inhibitors |
10/28/1998 | EP0873355A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione |
10/28/1998 | EP0873349A1 Endothelial-monocyte activating polypeptide iii |
10/28/1998 | EP0873348A1 Human vascular endothelial growth factor 3 |
10/28/1998 | EP0873345A1 Preparation of glucosaminyl muramic acid derivatives |
10/28/1998 | EP0873295A1 Dimer-selective rxr modulators and methods for their use |
10/28/1998 | EP0873141A1 Compositions and methods for therapeutic use |
10/28/1998 | EP0873140A2 Immunoconjugate for the treatment of aids |
10/28/1998 | EP0873136A2 High fluorescence specific immune enhancing factor and methods of use for same |
10/28/1998 | EP0873135A1 Peanut allergens and methods |
10/28/1998 | EP0873134A1 Aqueous prolonged release formulation |
10/28/1998 | EP0873133A1 Biologically active composition comprising cyclosporine |
10/28/1998 | EP0873132A1 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO |
10/28/1998 | EP0734247B1 Cosmetic and/or pharmaceutical preparations |
10/28/1998 | EP0656887B1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
10/28/1998 | EP0605484B1 Peptides having growth hormone releasing activity |
10/28/1998 | EP0598717B1 Duplex printer |
10/28/1998 | EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
10/28/1998 | CN1197461A Truncated glial cell line-derived neurotrophic factor |
10/28/1998 | CN1197460A Cyclic peptide analogs of somatostatin |
10/28/1998 | CN1197454A Penicillaminamide derivative |
10/28/1998 | CN1197396A Copolymeric micelle drug compsn. and method for the prepn. thereof |
10/28/1998 | CN1197394A Compsns. and methods for catalyzing hydrolysis of HIV gp120 |
10/28/1998 | CN1197393A Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
10/28/1998 | CN1197392A Prepn. of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
10/28/1998 | CN1197390A Transdermal matrix system |
10/28/1998 | CN1197389A Transdermal matrix system |
10/28/1998 | CN1196955A Thebaica giving-up vaccinum for man |
10/28/1998 | CN1040432C Spiro piperdines derivatives and its prepn. and applications |
10/28/1998 | CA2231746A1 A human sodium dependent phosphate transporter (ipt-1) |
10/27/1998 | US5827935 Chimeric tRNAlys -ribozyme molecules |
10/27/1998 | US5827934 Cytotoxic diphtheria toxin fragments |
10/27/1998 | US5827893 Mechanical and pharmacological therapies to treat cardiac arrest |
10/27/1998 | US5827866 Anticoagulants |
10/27/1998 | US5827860 Peptidyl heterocycles useful in the treatment of thrombin related disorders |
10/27/1998 | US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease |
10/27/1998 | US5827829 Use of a hymenoptera venom for the manufacture of a medicament for treating DNA virus infections |
10/27/1998 | US5827828 Sulfated glycolipids and antibodies thereto for prophylaxis or therapy of diabetes |
10/27/1998 | US5827827 Mimetic oligopeptide containing a 1-epoxy ethylene group replacing an amide peptide linkage in the backbone; side effect reduction, virus does not develop drug resistance |
10/27/1998 | US5827826 Compositions of human endothelial cell growth factor |
10/27/1998 | US5827825 Polypeptide from the condensation of variable hexa- or heptapeptides with peptides containing twelve to twenty units of leucine and/or norleucine, for treatment of respiratory disorders |
10/27/1998 | US5827824 Protease-resistant thrombomodulin analogs |
10/27/1998 | US5827823 Method of producing analgesia using neurotrophins |
10/27/1998 | US5827822 Aqueous suspension of cyclosporin particles and polyoxyethylene glycol surfactant |
10/27/1998 | US5827821 Conformationally stabilized cell adhesion peptides |
10/27/1998 | US5827820 Aqueous peritoneal dialysis solution |
10/27/1998 | US5827818 Anticoagulants; administered by injections along with a carrier |
10/27/1998 | US5827817 P-selectin ligand protein |
10/27/1998 | US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid |
10/27/1998 | US5827740 A mixture of glucocorticoids and an adenosine monophosphates inducing the fat cells by cell differentiation |
10/27/1998 | US5827736 Hybridomas having both immunoprotective and secretory activity, viability and functionality after transplanting, islet or chromaffin cells, for treatment of diabetes or parkinson's disease |
10/27/1998 | US5827735 Pluripotent mesenchymal stem cells and methods of use thereof |
10/27/1998 | US5827734 Materials and methods for determining ob protein in a biological sample |
10/27/1998 | US5827731 Anticoagulant |
10/27/1998 | US5827723 Neutralizing monoclonal antibody 0.5β which binds an epitope located within the region of amino acids 308-331 of HTLVIIB gp120 |
10/27/1998 | US5827721 BH55 hyaluronidase |
10/27/1998 | US5827711 Succinate-ubiquinone reductase subunit |
10/27/1998 | US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells |